We report the heavy chain variable region sequences from the cDNAs of five previousty described mono- 
variable regions derive from the VHIV gene family, but each has arisen from a different heavy chain variable region (VH) gene segment within the VHIV family. In addition, one is derived from a VHI gene segment, and one is derived from a VHV gene segment. Since four of the five antibodies arise from known germ-line VH elements, a precise determination of the extent of somatic variation is possible. The amount of variation from the closest germ-line sequence ranges from 4.5% to 14.8% among these antibodies, most of which is concentrated in the complementarity-determining regions. In general, the diversity (D) segments are long, characteristic of D-D fusions and/or extensive terminal deoxynucleotidyltransferase activity; however, definitive homologies cannot be found with the known germ-line D segments. Joining (JH) gene segment utilization appears random. The use offive different germ-line VH gene segments and extensive somatic mutation provides evidence that a polyclonal, antigen-driven immune response occurs during the natural infection with human immunodeficiency virus.
Immunoglobulin heavy and light chain variable regions are formed through the rearrangement of germ-line variable (VH), diversity (D) , and joining (JH) gene segments and variable (VL) and joining (JL) segments, respectively (1) . The subsequent association of the two variable regions and the operation of several mechanisms of somatic variation provide the antibody specificity that is crucial in a humoral immune response.
In humans, the immunoglobulin heavy chain complex consists ofvariable region (VH) gene segments that have been divided into six families (2) (family members are '80%o homologous to each other at the nucleotide level), >20 D segments (3) (4) (5) (6) , and six functional JH gene segments (4) . The VHI, VHII, and VHIII families were originally designated as such from the amino acid sequences of myeloma proteins (7) and were later confirmed at the nucleotide level (5, (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . The smaller, more recently described VHIV, VHV, and VHVI gene families were discovered by several methods, including sequencing of overlapping cosmid clones (VHIV and VHVI) (11, (19) (20) (21) , PCR amplification from genomic DNA (22) , sequencing VHDJH rearrangements from chronic lymphocytic leukemia patients (VHV) (23) , and sequencing fetal liver cDNA clones (VHVI) (24) .
Why most mammals maintain multiple VH gene segments and VH gene families is unknown. It is, however, possible that multiple genes and/or families are preserved because different genes are required for different types of antibody responses (e.g., polysaccharide vs. protein or viral vs. bacterial) or for regulatory purposes (e.g., self vs. exogenous antigens). Although the overall adult mouse repertoire appears to be "normalized" according to the size of the VH family (25) , there is a considerable body of experimental evidence that suggests that there may be a restricted VH gene usage in certain responses such as anti-carbohydrate (26, 27) , anti-phosphocholine (28) , and anti-p-azophenylarsonate antibodies (29) . VH gene segment restriction is also evident in the fetal repertoire. During murine ontogeny the repertoire is overrepresented by those VH genes that are the most D-proximal (30) . In the human fetal repertoire, there is also evidence for VH gene restriction, and, although it includes the single VHVI gene, it is not limited only to D-proximal genes (24, 31) . With the acquisition of more advanced human hybridoma technology and Epstein-Barr virus (EBV) transformation, a considerable amount of information now exists regarding human autoantibodies, such as anti-DNA, rheumatoid factors, cold agglutinins, and anti-acetylcholine receptor antibodies (32) . In general, it seems as though they, too, can arise from a restricted set of VH gene segments, often with little or no somatic mutation. The repertoire in chronic lymphocytic leukemia and acute lymphocytic leukemia B cells also largely results from utilizing relatively few VH gene segments (32) . Many of the same VH gene segments used in the fetal repertoire are also expressed in a number of autoantibodies and B-cell malignancies (33) . Although this restricted set of germ-line genes includes members from each of the six VH gene families, together they represent only a small percentage of the total number of VH gene segments. Whether this set of germ-line genes is reserved for certain subsets of B cells or whether they can be used in responses to an exogenous antigen is still unknown.
We have begun to address some of these issues by studying the heavy chain variable regions of antibodies that clearly arose as a result of exposure to exogenous antigens. The heavy chain variable region sequences of five human monoclonal antibodies (mAbs) specific for the human immunode- IlTo whom reprint requests should be addressed at *.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. ficiency virus type 1 (HIV-1) are reported here.** The cell lines were derived by EBV transformation of peripheral blood lymphocytes from HIV-positive individuals (34, 35) . Three of the five variable regions are members of the VHIV family, one derives from the VHV gene family, and one derives from the VHI gene family. By determining the nucleotide sequences of these antibodies, we hoped to assess the germ-line origin as well as the role of somatic variation present in antibodies that arise during the course of a natural infection that results from exposure to a relatively new human pathogen.
MATERIALS AND METHODS
Generation and Characterization of Human mAbs to HIV. Cell lines producing human mAbs to HIV were derived from peripheral blood cells from HIV-infected patients who were asymptomatic at the time the cell lines were developed. As previously described, lymphoblastoid cell lines were obtained by EBV transformation (34) or by fusion of EBVtransformed cells with the SHM-D33 heteromyeloma (35) , generously provided by N. Teng. Cells producing antibodies specific for HIV were identified by reactivity on ELISA either with whole HIV lysates or with a 23-mer peptide whose sequence is identical to that which spans the tip ofthe V3 loop of HIVMN. Five mAbs from three patients were studied; these include 98-6 (IgG2) and 120-16 (IgG2), both ofwhich are specific for a region in gp41 that maps to amino acids 644-663 (S.Z.-P., unpublished observations), 71-31 (IgGi), which is specific for p24, and 257-D (IgGl) and 268-D (IgGl), both of which are specific for the principal neutralizing domain of gpl20 of MN and map to residues KRIHI and HIGPGR, respectively. mAbs 257-D and 268-D have been shown to neutralize HIVMN but not HIVIIb (35) .
Oligonucleotides, First-Strand cDNA Synthesis, and PCR. Oligonucleotide primers and conditions used in the PCR amplifications and cDNA synthesis have been described (36) .
Isolation, Cloning, and Sequencing of the Amplified Products. Amplified DNA was size selected on a 1% agarose gel, ligated into the Sma I site of pTZ19U phagemid vector, and transformed into CaCl2 competent BSJ72 bacteria. Singlestranded DNA used for sequencing was isolated from positive clones following superinfection with M13K07 as described (37) . Sequencing was carried out on a minimum of four clones (both strands) using the dideoxy chaintermination method of Sanger (38) with a modified version of T7 DNA polymerase (Sequenase, United States Biochemical) (39) . Clones 268-D and 257-D were also isolated by cDNA cloning and sequencing.
RESULTS

Cloning and Sequencing the Expressed VH Genes Encoding
Anti-HIV-1 Antibodies. The complete variable region sequence of each antibody is shown in Fig. 1 . The VH120-16 gene is a member of the VHIV gene family and is most homologous to the previously described V71-2 germ-line gene (87.2%) (19) . The VH98-6 gene segment is 85.2% identical to the V2-1 germ-line gene (19) , another VHIV family member. The VH268-D gene is also a member of the VHIV gene family and is 88.5% identical to the V71-4 germ-line gene (19) . The VH region of antibody 71-31 derives from a VHI germ-line gene, but the closest homology with any known VHI gene (HG3) (8) is based on a 3-base-pair gap in CDR2. The last variable region, VH257-D, derives from a VHV gene segment, VH251 (23) (95.5% homology). Fig. 2 shows each of the expressed variable regions compared to their likely, respective, germ-line equivalents. The percent nucleotide difference ranges from 4.5% to 14.8%. As expected for an antigen-driven immune response, there are numerous nucleotide differences within the CDRs. With the exception of VH268-D, there are an unusual number of nucleotide differences in the framework regions, in particular in framework III, when compared to the analogous germ-line sequences. This degree of variation exceeds the usual mutation rate for frameworks (i.e., 2%), suggesting a role for framework residues in antigen binding (40) . More than 50%6 of the total mutations result in amino acid interchanges, suggesting an antigen-driven process.
Analysis of the D and JH Gene Segments. There are >20 known germ-line D segments and six functional JH segments in the human heavy chain complex. In expressed variable regions, the D segment (and the D-JHjunction) comprises the third CDR and is of major importance in generating antibody specificity and diversity. We found little homology between the expressed D segments and the known germ-line D segments, suggesting, as others have postulated (32) , that there are additional, as yet unknown, D segments. It is, therefore, difficult to distinguish between the actual D gene and those nucleotides that may represent N segment addition by terminal deoxynucleotidyltransferase (41) . In the murine system, it has been shown that additional D segment diversity can be generated by inverted D segments, D-D fusions, and inverted D-D fusions (42) . The 71-31 D segment represents a possible inverted D segment, as it is most homologous to a germ-line D segment, DM2 (6) , in the opposite transcriptional orientation. Additionally, the D segments in antibodies 268-D and 257-D appear to result from the fusion of an inverted D segment to a second D segment. Another type ofjunctional diversity, termed "P" (palindrome) nucleotides, was first described in murine T-cell receptor genes to account for recurring mono-and dinucleotides at the V-J junction (43) . There is one example of possible P nucleotide addition at the VH-D junction in antibody 120-16 where the presence of the dinucleotide, TC, creates a palindrome (Fig. 1A) .
Among the five antibodies, three express the JH4 gene segment, one expresses JH2, and one expresses JH3. It is thought that the somatic "mutase" is random and can target sequences in the 5' and 3' untranslated regions as well as in the coding region of VH, D, and JH (44); therefore it is not unexpected that some nucleotide differences are present in the expressed JH segments when compared to their respective germ-line equivalents. Some of the germ-line JH segments have been shown to be polymorphic (36, 45) . In all of the expressed JH4 gene segments reported here, an example ofthis polymorphism is seen where there is a "G" rather than an "A" at nucleotide 21 (Fig. 1B ), nucleotide 9 ( Fig. 1C) , and nucleotide 21 (Fig. 1E ) of the respective JH segments. DISCUSSION To date, the experimental data regarding the human immunoglobulin heavy chain repertoire come mainly from two sources: (i) the amino acid and nucleotide sequences of myeloma proteins and fetal and chronic lymphocytic leukemia VHDJH rearrangements, most of which are of unknown specificity (representing the bulk of the data), and (it) monoreactive and polyreactive autoantibodies of known specificity. There is little structural information regarding antibodies to exogenous antigens (46) (47) (48) (49) . Therefore Immunology: Andris et al. ATs AAA CAC CTG TOO TTC TTC CTC CTG CTG GTG GCA OCT CCC AGA TOO OTC CTG TCC CTC CTG CAA CTA CAG GAG TCC GGC 
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Comparison of these variable region sequences with their To understand the process by which an expressed variable likely germ-line equivalents suggests that they arose from region has evolved, it is critical to know its germ-line origin.
Proc. NatL. Acad. Sci. USA 88 (1991) A ********CCDRI***** V71-2
-*********CD21******** 
s continual and vigorous antigenic stimulation, by the fact that antibody-producing cells circeripheral blood (50) and antibody titers to viral in HIV-infected individuals are extraordinarily der such circumstances, one might expect to s resulting from antigen-driven selection over a lnths or even years. The data presented here iew. Although we have not completely ruled out of additional germ-line VH gene segments, the iation is striking in the CDRs and framework erally somatic mutation is thought to occur mmunoglobulin variable regions, but it is largely DRs due to antigen selection. Although the five Dns presented here are also mutated in the gions, in no instance are the frameworks more the CDRs. Fig. 3 shows the deduced amino acid 257-D compared to the deduced amino acid he VHV germ-line gene, VH251 (23) . There are [V germ-line genes and it is clear that VH251 has this expressed antibody. There is a total of five fferences (1.7%) (Fig. 2E) within the framewhich result in a change in the amino acid), Proc. Natl. Acad. Sci. USA 88 (1991) 7787 which is close to the expected framework variation of 2.0o, whereas there is 16-22% variation in the two CDRs-10 times the framework variation. This antibody provides a striking example of selection by antigen.
Early studies demonstrated that HIV immune sera from infected patients did not prevent HIV infection in chimpanzees that were challenged with virus (52) . In contrast, more recent studies have demonstrated that HIV hyperimmune human immunoglobulin preparations can passively protect chimpanzees that are challenged with human T-lymphotropic virus type IIIB (53) . Similarly, polyclonal chimpanzee IgG with HIV neutralizing activity has been shown to protect against challenge with the virus (54) . Since some antibodies that bind HIV have been shown to enhance the infection, rather than neutralize the virus (55), these conflicting results may be explained, in part, by the heterogenous nature of the immunoglobulin preparations used-i.e., protection may depend on the absence of enhancing antibodies. The molecular characterization of the HIV-1 antibodies studied here provides an opportunity for the expression and production of a homogeneous preparation of neutralizing antibodies.
Finally, these data, in addition to other, unpublished observations, indicate that a majority of the human B-cell repertoire to exogenous antigens arises from a distinct set of germ-line genes rather than from the genes used by the fetal, leukemic, and autoimmune repertoires (33) . This suggests that at least some VH germ-line genes are reserved for the latter purposes and may play a regulatory role in the expression of other VH genes used in a normal immune response. If such a VH gene utilization bias exists it would indicate that repertoire development is not as random as initially believed. The analysis of additional antibodies specific for exogenous antigens should provide further insight into this matter.
